Overview Financials News + Filings Key Docs Charts Ownership Insiders |
SUSSEX BANCORP (SBBS)
|
Add to portfolio |
|
|
Price: |
$18.67
| | Metrics |
OS: |
9.43
|
M
| |
11
|
% ROE
|
Market cap: |
$176
|
M
| |
6
|
% ROIC
|
|
|
| |
|
|
|
|
| | | |
| | | | | |
TTM Valuation | | | |
|
|
| |
|
|
|
|
| |
|
|
EPS |
$2.33
| |
8.0
|
x P/E
|
BVPS
|
$20.66
| |
0.90
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
Revenues | 70.9 | 53.4 | 35.8 | 30.9 | 25.9 | 22.4 | 19.8 | 18.8 |
Revenue growth | 32.7% | 49.2% | 15.7% | 19.5% | 15.4% | 13.3% | 5.0% | -0.3% |
Cost of goods sold | 28.3 | 23.5 | 16.7 | 14.9 | 13.3 | 11.7 | 10.8 | 10.4 |
Gross profit | 42.6 | 29.9 | 19.1 | 16.0 | 12.6 | 10.7 | 9.0 | 8.4 |
Gross margin | 60.0% | 56.0% | 53.5% | 51.7% | 48.8% | 47.8% | 45.5% | 44.6% |
Selling, general and administrative | | | | | | | | |
Sales and marketing | 0.5 | 0.6 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
General and administrative | 6.1 | 5.3 | 3.8 | 3.4 | 1.1 | 3.0 | 2.5 | 2.3 |
EBITA | 34.5 | 22.9 | 11.4 | 7.9 | 6.5 | 3.3 | 1.2 | -1.4 |
EBITA margin | 48.7% | 42.8% | 31.8% | 25.6% | 25.2% | 14.8% | 5.9% | -7.4% |
Amortization of intangibles | 0.4 | 0.2 | | | | | 0.0 | 0.0 |
EBIT | 34.1 | 22.6 | 11.4 | 7.9 | 6.5 | 3.3 | 1.2 | -1.4 |
EBIT margin | 48.1% | 42.4% | 31.8% | 25.6% | 25.2% | 14.8% | 5.9% | -7.4% |
Pre-tax income | 29.6 | 13.0 | 10.2 | 8.4 | 5.3 | 3.6 | 1.6 | 0.4 |
Income taxes | 7.1 | 3.1 | 4.5 | 2.8 | 1.6 | 1.0 | 0.1 | -0.3 |
Tax rate | 23.9% | 23.6% | 44.0% | 33.9% | 30.7% | 27.8% | 8.5% | |
Net income | 22.5 | 9.9 | 5.7 | 5.5 | 3.7 | 2.6 | 1.4 | 0.7 |
Net margin | 31.8% | 18.6% | 15.9% | 17.9% | 14.3% | 11.6% | 7.2% | 3.9% |
|
Diluted EPS | $2.40 | $1.25 | $1.05 | $1.19 | $0.81 | $0.57 | $0.37 | $0.22 |
Shares outstanding (diluted) | 9.4 | 7.9 | 5.4 | 4.7 | 4.6 | 4.6 | 3.8 | 3.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|